Development of Small Molecule Hsp90 Inhibitors: Utilizing Both Forward and Reverse Chemical Genomics for Drug Identification

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|9|733-739

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.9, 2003-05, pp. : 733-739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90

By  

Current Cancer Drug Targets, Vol. 3, Iss. 5, 2003-01 ,pp. : 371-376

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of purine-scaffold Hsp90 inhibitors

By Chiosis Gabriela   Kang Yanlong   Sun Weilin  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 99-114

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of Pyrazole-Scaffold Hsp90 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1193-1203

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of Purine-Scaffold Hsp90 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-01 ,pp. : 1183-1191

Bentham Science Publishers

Access to resources Recommend Favorite

Assays for Identification of Hsp90 Inhibitors and Biochemical Methods for Discriminating their Mechanism of Action

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 15, 2009-11 ,pp. : 1462-1478

Bentham Science Publishers

Access to resources Recommend Favorite